Healios K.K. (OTCMKTS:HLOSF – Get Free Report)’s share price was down 28.9% during mid-day trading on Thursday . The company traded as low as $0.96 and last traded at $0.96. Approximately 100 shares traded hands during trading, a decline of 96% from the average daily volume of 2,332 shares. The stock had previously closed at $1.35.
Healios K.K. Stock Down 28.9 %
The business’s fifty day simple moving average is $1.36 and its 200 day simple moving average is $1.39.
Healios K.K. Company Profile
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Further Reading
- Five stocks we like better than Healios K.K.
- How is Compound Interest Calculated?
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
